Barclays PLC Buys 38,763 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

Barclays PLC boosted its position in The Pennant Group, Inc. (NASDAQ:PNTG) by 375.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,101 shares of the company’s stock after purchasing an additional 38,763 shares during the period. Barclays PLC owned about 0.14% of The Pennant Group worth $1,753,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Quarry LP lifted its position in shares of The Pennant Group by 371.6% during the 3rd quarter. Quarry LP now owns 1,014 shares of the company’s stock valued at $36,000 after buying an additional 799 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. increased its holdings in The Pennant Group by 460.2% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,311 shares of the company’s stock worth $118,000 after acquiring an additional 2,720 shares during the last quarter. USA Financial Formulas bought a new stake in The Pennant Group in the 3rd quarter valued at about $121,000. Intech Investment Management LLC purchased a new stake in The Pennant Group during the third quarter valued at about $232,000. Finally, Summit Global Investments bought a new position in The Pennant Group during the third quarter worth about $254,000. 85.88% of the stock is owned by institutional investors.

The Pennant Group Stock Down 1.7 %

Shares of NASDAQ:PNTG opened at $26.63 on Friday. The firm has a fifty day moving average price of $30.97 and a two-hundred day moving average price of $30.33. The company has a market cap of $914.69 million, a price-to-earnings ratio of 39.16, a PEG ratio of 2.99 and a beta of 1.95. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The Pennant Group, Inc. has a one year low of $13.77 and a one year high of $37.13.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Oppenheimer upped their price target on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research note on Friday, November 8th. Stephens reissued an “overweight” rating and set a $40.00 target price on shares of The Pennant Group in a report on Wednesday, October 9th. Truist Financial increased their target price on The Pennant Group from $34.00 to $38.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. Wells Fargo & Company began coverage on The Pennant Group in a research note on Thursday, December 19th. They set an “equal weight” rating and a $33.00 price objective on the stock. Finally, Royal Bank of Canada increased their price objective on The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a report on Wednesday, October 23rd. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $37.20.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.